Dudediligence.

TELA Bio, Inc

TELANASDAQ · Surgical & Medical Instruments & Apparatus
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$19.0MSep ’24$17.6MDec ’24$18.5MMar ’25$20.2MJun ’25$20.7MSep ’25$20.9MDec ’25$19.1MMar ’26$19.3MJun ’26
Net income, by quarter
−$10.4MSep ’24−$9.2MDec ’24−$11.3MMar ’25−$9.9MJun ’25−$8.6MSep ’25−$9.0MDec ’25−$12.3MMar ’26−$11.3MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$29.5M$41.4M$58.5M$69.3M$80.3M
Gross profit$18.8M$27.0M$40.1M$46.5M$54.3M
Operating income−$29.5M−$39.0M−$44.1M−$34.1M−$33.8M
Net income−$33.3M−$44.3M−$46.7M−$37.8M−$38.8M
Operating cash flow−$30.4M−$40.7M−$40.9M−$41.6M−$28.2M
Free cash flow−$31.1M−$41.6M−$41.5M−$42.6M−$28.7M
Cash$43.9M$42.0M$46.7M$52.7M$50.8M
Debt$31.5M$39.9M$40.5M$41.1M$55.7M
Shares outstanding14.5M19.2M24.5M39.4M44.5M